Gilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.
LEARN MOREIndicated to suppress estrus in mares. Suppression of estrus will also facilitate management of prolonged estrus conditions.
LEARN MORETriple-action, once-a-day treatment for 7 days for even the most stubborn cases associated with susceptible strains of yeast and bacteria in canines.
LEARN MOREFor the prevention and treatment of Selenium-Tocopherol Deficiency (white muscle disease) syndrome in calves.
LEARN MORE